ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma.
Marina Georgiou,
Panagiota Ntavelou,
William Stokes,
Rajat Roy,
Geoffrey J Maher,
Tsvetana Stoilova,
Josephine AMY Choo,
Callum P Rakhit,
Miguel Martins,
Paul Ajuh,
Neil Horowitz,
Ross S Berkowitz,
Kevin Elias,
Michael J Seckl,
Olivier E Pardo
OAI: oai:www.repository.cam.ac.uk:1810/337747 • DOI: 10.17863/CAM.85156